Today’s headlines reflected an industry in constant transition, as leadership changes, pipeline milestones and strategic investments reshaped biopharma’s path to future growth. AstraZeneca quarterly net profit rises 2% on strong cancer drug sales AstraZeneca board Amgen sheds around 40 staffers amid continuing struggles Amgen board Otsuka’s ADHD approval opens up new drug class with $615M opportun
cafepharma.com appears in the published seller files of 1 advertising network. Each row below is that network's own declaration that it is authorised to sell this site's inventory, with the date the relationship first appeared in the record.
Same niche, closest authority score — the competitive set a network would compare cafepharma.com against.